INTELLIA THERAPEUTICS INC (NTLA)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for NTLA
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| NTLA | Chairperson of the Board of Directors | 63 | ["Former president and CEO of Axcan Pharma, Inc.","Served on the board of directors of Axcan","Continued responsibilities after Axcan went private","Involved with Aptalis Pharma, Inc. after it was acquired"] | [] | 2026 |
Biography sourced from the proxy statement filing.
Dr. Verwiel served on the audit committee throughout 2025 and on the nominating and corporate governance committee throughout 2025, serving as committee chair of the nominating and corporate governance committee. Our board of directors has determined that Dr. Verwiel is independent for audit committee purposes as that term is defined in the applicable rules of the SEC and Nasdaq.